癌症研究档案

  • 国际标准期刊号: 2254-6081
  • 期刊 h 指数: 13
  • 期刊引用分数: 3.58
  • 期刊影响因子: 3.12
索引于
  • 中国知网(CNKI)
  • 引用因子
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

Study of the Role of Anti-Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissues

A Heidari

The intermolecular forces between anti–cancer molecules such as Cisplatin, Carboplatin, Oxaliplatin, Nedaplatin, Lobaplation, Heptaplatin, Dicycloplatin, Eleutherobin, Epothilone B, Discodermolide and Taxol and tumor multiple organs or tissues are of great importance in many areas of science including medicine, chemotherapy, pharmacology, medicinal chemistry, pharmaceutical chemistry, biochemistry and so on. As a result, these molecular systems have received a great significant of attention in both computational and theoretical aspects.